The Cannabis Catch-Up is a convenient and easy to read daily summary of the top cannabis stock news.
We’ve scanned the newsfeeds of all the important marijuana stocks and put together this recap so you don’t have to.
Top News Stories for Tuesday, September 17, 2019:
Bruce is Back: Linton Makes His Highly Anticipated Return to the Cannabis Sector
After nearly two months of waiting, Bruce Linton is making his long-awaited return to the industry he helped build.
After founding and building the world’s largest cannabis company Canopy Growth (TSX: WEED) (NYSE: CGC), Linton has turned over a new leaf and today announced his multiple new initiatives.
READ FULL BRUCE LINTON ARTICLE
CannTrust’s Cannabis Licences Suspended by Health Canada, Is This the Death Blow?
The verdict is finally in on CannTrust Holdings (TSX: TRST) (NYSE: CTST) after it was reported today that Health Canada has informed the company of its decision to suspend its cannabis cultivation and sales licenses.
Health Canada dropped the hammer on CannTrust, but is there still light at the end of the tunnel for the once-great licensed producer?
Supreme Cannabis Reports Q4 and FY 2019 Earnings
Supreme Cannabis (TSX: FIRE) (OTCQX: SPRWF) announced today the results of its fourth quarter and fiscal year ended June 30, 2019 earnings.
- Supreme reported its first positive adjusted EBITDA quarter of $3.2 million.
- Q4 net revenue came in at $19 million, up 90% over Q3 2019.
- Fiscal 2019 total revenue was $41.8 million, up 370% over fiscal 2018.
Cresco Labs and Origin House Comply with DOJ’s 2nd Request
Cresco Labs (CSE: CL) (OTCQX: CRLBF) and Origin House (CSE: OH) (OTCQX: ORHOF) announced today via joint press release, effective September 16, 2019, they have each submitted certifications of substantial compliance with the U.S. DOJ’s request for additional information in regards to their pending merger.
“Today’s announcement marks the crossing of yet another significant hurdle towards the completion of the Transaction. We are pleased to announce that both companies have now submitted their responses and look forward to closing the Transaction following the expiration of the applicable antitrust waiting period,” stated Cresco Labs CEO Charlie Bachtell.
READ FULL CRESCO LABS/ORIGIN HOUSE PR
TerrAscend Completes Ilera Healthcare Acquisition
TerrAscend (CSE: TER) (OTCQX: TRSSF) announced the closing of its previously announced acquisition of Pennsylvania-based Ilera Healthcare.
TerrAscend expands its licensed footprint into four U.S. states in addition to Canada and Europe.
Canopy Growth Stakeholders Elect 7 Board Members
Canopy Growth (TSX: WEED) (NYSE: CGC) announced today that all of the company’s nominees listed in its August 8, 2019 management information circular were elected as directors of the company at Canopy Growth’s annual general meeting (AGM).
The results and details of the AGM vote can be view via the link below.
Heritage Announces JV with Empower Clinics to Produce Hemp-Derived CBD Oil
Heritage Cannabis (CSE: CANN) (OTCQX: HERTF) announced its LOI with Empower Clinics (CSE: CBDT) to form a JV Partnership.
The JV will be based in Sandy, Oregon USA for the purpose of extracting hemp-derived CBD oil to produce and formulate CBD products.
READ FULL HERITAGE CANNABIS PR
1933 Industries Issues Statement on its Vape Products
1933 Industries (CSE: TGIF) (OTCQX: TGIFF) released a statement today in regards to its vape products. Below is an excerpt from the company’s statement.
“All our branded THC and CBD vape products do not contain vitamin E acetate, vegetable glycerin, or propylene glycol. All our products are made with ingredients that are known to be safe for consumers. All packaging contains our product ingredients, which are also listed on our website. Each and every product is third-party lab tested, and the results can be tracked via a QR code.”
Canopy Rivers Portfolio Company Licenses Syqe™ Inhaler
Canopy Rivers (TSX: RIV) (OTCPK: CNPOF) announced its portfolio company, TerrAscend (CSE: TER) (OTCQX: TRSSF), has entered into a distribution agreement with Syqe Medical, an Israel-based pharma-tech company, to launch the Syqe™ Inhaler, in Canada.
The Syqe Inhaler is the world’s first metered-dose medical cannabis inhaler and will provide Canadians with an alternative to dried flower medical cannabis.
The Most Anticipated Cannabis IPO of 2019 Has Finally Arrived
Move Over Curaleaf, There’s a New MSO in Town and it’s Set to Hit The Street This September
Get the full details here so you don’t miss out on the next potential 10 bagger.
*Get Your Copy of The Ultimate Cannabis Investing Guide*
Join the Discussion and Share Your Own Stock Picks in the TCI Facebook Group
Featured ArticlesCannabis Stock NewsCannabis Industry ArticlesTechnical Analysis ArticlesWatch Cannabis Stock Videos